Brian Wright analyst

Currently out of the existing stock ratings of Brian Wright, 24 are a BUY (85.71%), 4 are a HOLD (14.29%).

Brian Wright

Work Performance Price Targets & Ratings Chart

Analyst Brian Wright works with a stock forecast success ratio of 21% fulfilled within 47.2 days on average.

Brian Wright’s has documented 56 price targets and ratings displayed on 10 stocks. The coverage was on Basic Materials, Industrials, Consumer Defensive sectors.

Most recent stock forecast was given on BIOX, Bioceres Crop Solutions Corp at 09-Feb-2024.

Wall Street Analyst Brian Wright

Analyst best performing recommendations are on EVGN (EVOGENE).
The best stock recommendation documented was for EVGN (EVOGENE) at 7/21/2023. The price target of $1 was fulfilled within 14 days with a profit of $0.13 (11.5%) receiving and performance score of 8.22.

Average potential price target upside

CTVA Corteva LNN Lindsay EVGN Evogene LOCL Local Bounti Corp ANDE The Andersons BIOX Bioceres Crop Solutions Corp PAHC Phibro Animal Health XXII 22nd Century Group ADM Archer-Daniels-Midland Company BG Bunge

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

57

$1.8 (3.26%)

56

12 days ago

10/13 (76.92%)

$3.24 (6.03%)

126

Buy

56

1 months 23 days ago

6/17 (35.29%)

$2.1 (3.90%)

92

Hold

65

$11.34 (21.13%)

70

2 months 13 days ago

6/9 (66.67%)

$9.95 (18.07%)

175

Hold

53

$-2.2 (-3.99%)

30

2 months 22 days ago

1/2 (50%)

$0.12 (0.23%)

5

Buy

63

$7.8 (14.13%)

62

2 months 22 days ago

7/13 (53.85%)

$10.12 (19.14%)

133

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Brian Wright is most bullish on?

Potential upside of $28.25 has been obtained for BG (BUNGE)

Which stock is Brian Wright is most reserved on?

Potential downside of -$0 has been obtained for CTVA (CORTEVA)

What Year was the first public recommendation made by Brian Wright?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?